Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd May Reduce Global Sales Team-Business Standard


Wednesday, 22 May 2013 03:19pm EDT 

Business Standard reported that Ranbaxy Laboratories Ltd is now considering downsizing its global sales force by around a third. A it is learn that majority of the job cuts would be in the US. Ranbaxy is planning to lay off field force globally, mainly in the US. The Company was contemplating this for some time, especially in view of the issues there. The business has suffered because of regulatory issues through past years. Besides, it also had to incur additional costs to settle those issues, an industry source told Business Standard. 

Company Quote

606.0
 --
24 Dec 2014